- Home
- GVP vs PMCB Comparison
GVP vs PMCB Comparison
Compare GVP & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GVP
- PMCB
- Stock Information
- Founded
- GVP 1994
- PMCB 1996
- Country
- GVP United States
- PMCB United States
- Employees
- GVP N/A
- PMCB N/A
- Industry
- GVP Computer Software: Prepackaged Software
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GVP Technology
- PMCB Health Care
- Exchange
- GVP Nasdaq
- PMCB Nasdaq
- Market Cap
- GVP 14.2M
- PMCB 15.8M
- IPO Year
- GVP 1995
- PMCB N/A
- Fundamental
- Price
- GVP $4.08
- PMCB $1.75
- Analyst Decision
- GVP Strong Buy
- PMCB
- Analyst Count
- GVP 1
- PMCB 0
- Target Price
- GVP $13.00
- PMCB N/A
- AVG Volume (30 Days)
- GVP 46.2K
- PMCB 37.3K
- Earning Date
- GVP 11-12-2024
- PMCB 09-17-2024
- Dividend Yield
- GVP N/A
- PMCB N/A
- EPS Growth
- GVP N/A
- PMCB N/A
- EPS
- GVP N/A
- PMCB 0.54
- Revenue
- GVP $44,789,000.00
- PMCB N/A
- Revenue This Year
- GVP $29.76
- PMCB N/A
- Revenue Next Year
- GVP $10.48
- PMCB N/A
- P/E Ratio
- GVP N/A
- PMCB $3.29
- Revenue Growth
- GVP N/A
- PMCB N/A
- 52 Week Low
- GVP $1.21
- PMCB $1.39
- 52 Week High
- GVP $5.38
- PMCB $2.58
- Technical
- Relative Strength Index (RSI)
- GVP 55.96
- PMCB 50.47
- Support Level
- GVP $4.02
- PMCB $1.72
- Resistance Level
- GVP $4.10
- PMCB $1.95
- Average True Range (ATR)
- GVP 0.04
- PMCB 0.23
- MACD
- GVP -0.01
- PMCB -0.01
- Stochastic Oscillator
- GVP 55.56
- PMCB 48.33
About GVP GSE Systems Inc.
GSE Systems Inc is a company engaged in providing engineering, staffing, and simulation software to clients in the power and process industries. It also provides interactive computer-based tutorials and simulation software for the refining, chemical, and petrochemical industries. It functions through two segments: The engineering segment and the Workforce Solutions segment. Its geographical segments include the United States, Europe, and Asia, out of which the majority of the revenue is generated from the United States.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.